packageAbciximab

abciximab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Abciximab is a platelet aggregation inhibitor used to treat unstable angina and acute myocardial infarction, mainly during and after coronary artery procedures. It is a hospital-administered injectable drug used mainly in cardiac care settings during angioplasty procedures.

Summary written by glm-5.3-flash from Wikidata Q307088 and the WHO ATC classification; not checked by a person.

name:abciximab
ATC codes:B01AC13
DrugBank:DB00054
Wikidata:Q307088
molar mass:145651 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown